APA (7th ed.) Citation

AR, N., C, S., TC, T., GC, W., SW, M., & TH, K. (2022). Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism. Journal of thrombosis and thrombolysis, 54(2), 276. https://doi.org/10.1007/s11239-022-02668-8

Chicago Style (17th ed.) Citation

AR, Novak, Shakowski C, Trujillo TC, Wright GC, Mueller SW, and Kiser TH. "Evaluation of Safety and Efficacy Outcomes of Direct Oral Anticoagulants Versus Warfarin in Normal and Extreme Body Weights for the Treatment of Atrial Fibrillation or Venous Thromboembolism." Journal of Thrombosis and Thrombolysis 54, no. 2 (2022): 276. https://doi.org/10.1007/s11239-022-02668-8.

MLA (9th ed.) Citation

AR, Novak, et al. "Evaluation of Safety and Efficacy Outcomes of Direct Oral Anticoagulants Versus Warfarin in Normal and Extreme Body Weights for the Treatment of Atrial Fibrillation or Venous Thromboembolism." Journal of Thrombosis and Thrombolysis, vol. 54, no. 2, 2022, p. 276, https://doi.org/10.1007/s11239-022-02668-8.